| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $137.2M | — | +43.0% |
| Cost of Revenue | $58.3M | — | +38.5% |
| Gross Profit | $78.9M | — | +46.5% |
| R&D Expense | $53.2M | — | -4.1% |
| SG&A Expense | $42.5M | — | +16.0% |
| Operating Income | -$17.2M | — | +62.7% |
| Pre-tax Income | -$18.7M | — | +61.9% |
| Income Tax | $26.5M | — | +3625.0% |
| Net Income | -$45.1M | — | +9.2% |
| EPS (Basic) | -$0.52 | — | +10.3% |
| EPS (Diluted) | -$0.52 | — | +10.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $61.1M | -16.1% | -40.6% |
| Accounts Receivable | $40.9M | -11.4% | -58.7% |
| Inventory | $85.8M | +9.9% | -0.2% |
| Current Assets | $249.4M | +0.2% | -22.1% |
| Total Assets | $771.3M | -3.2% | -9.8% |
| Current Liabilities | $146.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.9M | — | +22.2% |
| Capital Expenditures | $1.4M | — | -30.4% |
| Investing Cash Flow | -$4.2M | — | -113.1% |
| Financing Cash Flow | $2.3M | — | +206.4% |
| Free Cash Flow | -$10.3M | — | +23.4% |
| -25.5% |
| Long-term Debt | $123.8M | +0.1% | +0.5% |
| Total Liabilities | $317.1M | -8.0% | -12.4% |
| Stockholders' Equity | $454.2M | +0.5% | -7.9% |